These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38057480)

  • 1. Association between brain cancer immunogenetic profile and in silico immunogenicities of 11 viruses.
    Georgopoulos AP; James LM
    Sci Rep; 2023 Dec; 13(1):21528. PubMed ID: 38057480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative association between multiple sclerosis immunogenetic profile and in silico immunogenicities of 12 viruses.
    James LM; Georgopoulos AP
    Sci Rep; 2023 Oct; 13(1):18654. PubMed ID: 37907711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer, viruses, and human leukocyte antigen (HLA).
    James LM; Georgopoulos AP
    Sci Rep; 2024 Jul; 14(1):16179. PubMed ID: 39003313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants.
    Sundqvist E; Buck D; Warnke C; Albrecht E; Gieger C; Khademi M; Lima Bomfim I; Fogdell-Hahn A; Link J; Alfredsson L; Søndergaard HB; Hillert J; ; Oturai AB; Hemmer B; Kockum I; Olsson T
    PLoS Pathog; 2014 Apr; 10(4):e1004084. PubMed ID: 24763718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of association of Human Leukocyte Antigens A, B, C, DR and DQ with Human Papillomavirus 16 infection.
    Bhaskaran M; ArunKumar G
    Infect Genet Evol; 2019 Mar; 68():194-202. PubMed ID: 30590170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma and Human Leukocyte Antigen (HLA): Immunogenicity of 69 HLA Class I Alleles With 11 Antigens Expressed in Melanoma Tumors.
    Georgopoulos AP; James LM; Charonis SA; Sanders M
    Cancer Inform; 2023; 22():11769351231172604. PubMed ID: 37251656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
    Arndt MF; Koohestani DM; Chobrutskiy BI; Mihyu MM; Diaz M; Gozlan EC; Yeagley M; Zaman S; Roca AM; Blanck G
    Hum Immunol; 2020 Dec; 81(12):692-696. PubMed ID: 32950267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population.
    Moura RR; Agrelli A; Santos-Silva CA; Silva N; Assunção BR; Brandão L; Benko-Iseppon AM; Crovella S
    J Clin Pathol; 2021 Aug; 74(8):528-532. PubMed ID: 32759312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive Association Between the Immunogenetic Human Leukocyte Antigen (HLA) Profiles of Multiple Sclerosis and Brain Cancer.
    James LM; Georgopoulos AP
    Neurosci Insights; 2023; 18():26331055231214543. PubMed ID: 38046672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigens I and II haplotypes associated with human papillomavirus 16-positive invasive cervical cancer in Mexican women.
    Hernández-Hernández DM; Cerda-Flores RM; Juárez-Cedillo T; Granados-Arriola J; Vargas-Alarcón G; Apresa-García T; Alvarado-Cabrero I; García-Carrancá A; Salcedo-Vargas M; Mohar-Betancourt A
    Int J Gynecol Cancer; 2009 Aug; 19(6):1099-106. PubMed ID: 19820376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.
    Soto-Nava M; Avila-Ríos S; Valenzuela-Ponce H; García-Morales C; Carlson JM; Tapia-Trejo D; Garrido-Rodriguez D; Alva-Hernández SN; García-Tellez TA; Murakami-Ogasawara A; ; Mallal SA; John M; Brockman MA; Brumme CJ; Brumme ZL; Reyes-Teran G;
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico assessment of binding affinities of three dementia-protective Human Leukocyte Antigen (HLA) alleles to nine human herpes virus antigens.
    Charonis S; James LM; Georgopoulos AP
    Curr Res Transl Med; 2020 Nov; 68(4):211-216. PubMed ID: 32624427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
    Bontkes HJ; van Duin M; de Gruijl TD; Duggan-Keen MF; Walboomers JM; Stukart MJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ; Stevens FR; Dyer PA; Sinnott P; Stern PL
    Int J Cancer; 1998 Oct; 78(2):166-71. PubMed ID: 9754647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the immune interactions underlying HLA class I disease associations.
    Debebe BJ; Boelen L; Lee JC; ; Thio CL; Astemborski J; Kirk G; Khakoo SI; Donfield SM; Goedert JJ; Asquith B
    Elife; 2020 Apr; 9():. PubMed ID: 32238263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
    Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the impact on T- and B- cell epitopes of human papillomavirus type-16 E6 and E7 variant in Southwest China.
    Chenzhang Y; Wen Q; Ding X; Cao M; Chen Z; Mu X; Wang T
    Immunol Lett; 2017 Jan; 181():26-30. PubMed ID: 27693214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence.
    Ferguson R; Ramanakumar AV; Richardson H; Tellier PP; Coutlée F; Franco EL; Roger M
    Hum Immunol; 2011 Apr; 72(4):337-41. PubMed ID: 21256910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.
    Creary LE; Guerra SG; Chong W; Brown CJ; Turner TR; Robinson J; Bultitude WP; Mayor NP; Marsh SGE; Saito K; Lam K; Duke JL; Mosbruger TL; Ferriola D; Monos D; Willis A; Askar M; Fischer G; Saw CL; Ragoussis J; Petrek M; Serra-Pagés C; Juan M; Stavropoulos-Giokas C; Dinou A; Ameen R; Al Shemmari S; Spierings E; Gendzekhadze K; Morris GP; Zhang Q; Kashi Z; Hsu S; Gangavarapu S; Mallempati KC; Yamamoto F; Osoegawa K; Vayntrub T; Chang CJ; Hansen JA; Fernández-Viňa MA
    Hum Immunol; 2019 Jul; 80(7):449-460. PubMed ID: 30844424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk evaluation model of cervical cancer based on etiology and human leukocyte antigen allele susceptibility.
    Hu B; Tao N; Zeng F; Zhao M; Qiu L; Chen W; Tan Y; Wei Y; Wu X; Wu X
    Int J Infect Dis; 2014 Nov; 28():8-12. PubMed ID: 25223804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.